Physician profile
Subrat Behera
NPI 1487936563
$1,240.01
in general payments reported to CMS, 2019-2025
17 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $588 · 2020: $93.09 · 2021: $28.78 · 2022: $119 · 2023: $216 · 2024: $73.11 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $411.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $536.69 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $158.64 | 2019-2025 | |
| Pfizer INC. | $93.43 | 2019-2020 | |
| Mylan Specialty L.P. | $85.28 | 2019 | |
| Novartis Pharmaceuticals Corporation | $71.69 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $35.63 | 2019 | |
| W. L. Gore & Associates, INC. | $35.54 | 2024 | Gore Cardioform Septal Occluder |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $33.49 | 2025 | Lifevest |
| Allergan, INC. | $30.94 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $30.52 | 2019 | |
| Alexion Pharmaceuticals, INC. | $23.53 | 2022 | |
| Philips North America LLC | $20.70 | 2025 | Vest Therapy Und |
| Gilead Sciences, INC. | $20.43 | 2023 | Veklury |
| Amgen INC. | $17.53 | 2025 | Repatha |
| Ekos Corporation | $17.39 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $17.36 | 2022 | |
| Apria Healthcare LLC | $11.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Subrat Behera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.